Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr₹763 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹1,559 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr
Mar2021₹937 Cr
Mar2020₹763 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr
22.84
Mar2020 ₹763 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹15,468.4 Cr 15.3% -18.5% 65.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,269.0 Cr 1.6% -8.2% 4% Stock Analytics
DIVIS LABORATORIES ₹148,381.0 Cr 0.9% -8.7% 59.9% Stock Analytics
CIPLA ₹117,803.0 Cr 3.6% 1.5% -0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,974.0 Cr 3.8% -1.4% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹94,527.1 Cr 1.2% -7.8% -10.1% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

15.3%

-18.5%

65.4%

SENSEX

1.6%

-5.4%

0.7%


You may also like the below Video Courses